BackImmuron Limited - Warrants (12/05/2022) Overview

Immuron Limited - Warrants (12/05/2022) Total Assets

Latest total assets for IMRNW: $15M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$15.14M
24.39% YoYΔ $2.97M vs prior year quarter

Peer average

Loading

Immuron Limited - Warrants (12/05/2022) Total Assets History

Loading

Immuron Limited - Warrants (12/05/2022) vs. peers: Total Assets Comparison

Loading

Immuron Limited - Warrants (12/05/2022) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Immuron Limited - Warrants (12/05/2022) (IMRNW) FAQ

The latest total assets for IMRNW is $15M as of December 2025. That compares with $12M in the prior-year period — up 24.4% year over year. Investors often review this figure alongside Immuron Limited - Warrants (12/05/2022)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, IMRNW's total assets moved from $12M to $15M — a 24.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immuron Limited - Warrants (12/05/2022)'s operating scale or balance-sheet position.

A total assets figure of $15M for IMRNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMRNW's total assets ($15M), review year-over-year change from $12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Immuron Limited - Warrants (12/05/2022)'s total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.